Table 2.
Circulating | lncRNAs | Changes | Function | Reference |
---|---|---|---|---|
Plasma | BACE1–AS | High in plasm from 45 full-AD patients | AD progression and diagnosis | Fotuhi et al. (2019) |
Plasma | BACE1–AS | High in plasm exosome from 72 AD patients | AD diagnosis | Wang D. et al. (2020) |
Plasma | BACE1 | High in plasm from 88 AD patients | AD diagnosis | Feng et al. (2018) |
CSF; plasma | MALAT1 | Low in CSF and plasm from 120 AD patients | AD progression and diagnosis | Zhuang et al. (2020) |
Blood | MKRN2–42:1 | Low in peripheral blood from 32 PD patients | PD diagnosis and disease monitoring | Wang et al. (2020) |
Leukocytes | lnc-MOK–6:1; HOTAIRM1; RF01976.1–201; AC131056.3–001 | High in leukocytes from 72 PD patients | PD diagnosis | Fan et al. (2019) |
Serum | TUG1 | High in serum from 97 PD patients | PD progression and diagnosis | Cheng et al. (2020) |
Blood | NEAT1 | High in blood from 43 PD patients | PD diagnosis | Boros et al. (2020) |